The role of vascular endothelial growth factor and bevacizumab on the wound healing in trabeculectomy patients

Authors:Jiang Xiaodan,  Li Xuemin,  Wang Wei
DOI: 10.3760/cma.j.issn.2095-0160.2016.12.019
Published 2016-12-10
Cite as Chin J Exp Ophthalmol, 2016,34(12): 1136-1139.

Abstract

Proper wound healing and scaring are the key factor to the success of trabeculectomy in glaucoma patients.The inadequate wound healing will lead to bleb leakage and ocular hypotension after surgery; however, excessive wound healing and scaring will cause the failure of the surgery and eventually increase the intraocular pressure.The applying of antimetabolic drugs such as mitomycin C (MMC) and 5-fluorouracil (5-FU) are able to relieve the excessive wound healing in some degree; however, the side effects like ocular hypotension, dysesthesia endophthalmitis can never be ignored.What is worse, some patients are not sensitive to such drugs.Subconjunctival injection of CAT-152 (monoclonal antibody against transforming growth factor-β) was able to control wound healing in animal trabeculectomy model, while failed in multi-center clinical trial.Recent studies have focused on the role of vascular endothelial growth factor (VEGF) and VEGF inhibitors on the wound healing after trabeculectomy.This paper aims to review the mechanism of wound healing after trabeculectomy, as well as the role of anti-VEGF on this kind of wound healing and scaring.

Key words:

Glaucoma; Trabeculectomy; Wound healing; Anti-vascular endothelial growth factor

Contributor Information

Jiang Xiaodan
Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China
Li Xuemin
Wang Wei
(Read 45 times, 1 visits today)
Updated: September 24, 2019 — 2:58 am